Genprex Expands Manufacturing Program with Aldevron to Advance Oncoprex™ Clinical Development

Go back to Genprex Expands Manufacturing Program with Aldevron to Advance Oncoprex™ Clinical Development
(NASDAQ: GNPX) Delayed: 0.65 +0.01 (1.56%)
Previous Close $0.64    52 Week High
Open $0.64    52 Week Low
Day High $0.67    P/E N/A 
Day Low $0.62    EPS
Volume 127,710